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Abstract
Purpose This work aimed to design and validate a novel short food frequency questionnaire (SFFQ) to assess habitual intakes 
of food items related to non-alcoholic fatty liver disease (NAFLD) in a cohort of European patients.
Methods A 48-item SFFQ was created, with questions from existing FFQs and expert knowledge, emphasizing foods and 
nutrients implicated in NAFLD pathogenesis. Consenting, fibroscan-diagnosed, NAFLD patients completed the SFFQ dur-
ing a short interview and were asked to complete a 4-day diet diary (4DDD) at home for return by mail. Nutritional intakes 
were assessed utilizing the myfood24™ food composition dataset and estimated energy requirements (EER) were calculated 
using sex-, age- and weight-specific equations. Agreement between the dietary instruments was assessed by Spearman cor-
relations and Bland Altman analysis.
Results Fifty-five patients completed both the SFFQ and the 4DDD within 30 weeks; 42 (76%) were diagnosed with simple 
steatosis, whereas 13 (24%) had biopsy-proven steatohepatitis; the majority were overweight or obese, with a median (25th; 
75th percentile) BMI of 33.2 kg/m2 (29.3; 36.0). Reported energy intakes were well below EER with a median intake of 73% 
of requirements, suggesting widespread under-reporting. Significant correlations were observed between sugar (r = 0.408, 
P = 0.002), fat (r = 0.44, P = 0.001), fruits (r = 0.51, P = 0.0001) and vegetables (r = 0.40, P = 0.0024) measurements by the 
SFFQ and 4DDD. Bland Altman plots with regression analysis demonstrated broad comparability with the 4DDD for intakes 
of fat (bias − 13.8 g/day) and sugar (bias  + 12.9 g/day).
Conclusions A novel SFFQ designed to be minimally burdensome to participants was effective at assessing dietary intakes 
in NAFLD patients.
Keywords Short food frequency questionnaire · Non-alcoholic fatty liver disease · Diet · Nutrition
Introduction
Non-alcoholic fatty liver disease (NAFLD) is currently 
the leading cause of liver disease in the developed world 
with incidence corresponding to increasing obesity and 
diabetes trends worldwide [1]. Characterised by excessive 
fat accumulation in the liver, NAFLD diagnosis is based 
on the presence of steatosis in > 5% of hepatocytes and 
the exclusion of: significant alcohol consumption (> 30 g/
day for men; >20 g/day for women); use of hepatotoxic 
medications such as methotrexate, tamoxifen or steroids; 
and other liver diseases such as Hepatitis C viral infection, 
haemochromatosis, or Wilson’s Disease [2]. Histologically, 
NAFLD may range from simple steatosis (NAFL), where 
there is fatty infiltration but no evidence of hepatocellular 
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injury, to steatohepatitis (NASH), where there is evidence 
of inflammation and ballooning, with or without fibrosis 
[3]. Closely associated with obesity and co-morbidities such 
as type 2 diabetes, and cardiovascular disease, the preva-
lence of NAFLD varies across the world with estimates of 
17–46%, depending on diagnostic method, age and gender of 
the patient [1]. Given the similarities in aetiology, NAFLD 
is commonly described as the hepatic manifestation of the 
metabolic syndrome [4]. In particular, hyper-energetic diets, 
containing high levels of saturated fat, refined carbohydrates 
and sugar sweetened beverages, are strongly implicated in 
NAFLD pathogenesis. Currently, in the absence of exist-
ing first-line pharmacotherapy, dietary and lifestyle changes 
aimed at weight loss are fundamental to clinical manage-
ment guidelines [2, 3, 5]. Significant reduction in steatosis 
and hepatic markers of NAFLD has generally been observed 
with a weight loss of 5–10% [6].
In addition to excess energy, evidence is accumulating 
that dietary quality and specific dietary components may 
play a distinct role in NAFLD pathogenesis. Consistently, 
a ‘Western style’ diet, with high intakes of meat, saturated 
fat and sugar, and low intakes of fruits, vegetables, fibre 
and omega 3 polyunsaturated fats has been associated with 
NAFLD disease severity [7]. Given the challenge of sus-
taining weight loss for most people [8], altering dietary 
composition in the absence of caloric restriction may be 
more feasible and may improve steatosis and metabolic dys-
function in NAFLD [9]. Notably, in a recent trial examin-
ing the effects of isocaloric, ad libitum Mediterranean and 
low-fat diets on steatosis and cardiometabolic risk factors, 
both diets reduced liver fat significantly after 12-weeks to a 
similar degree, 25–32%, measured by magnetic resonance 
spectroscopy. Interestingly, while the intervention was not 
designed for weight loss, and there was no difference in the 
caloric intakes measured at baseline and 12-weeks, both 
groups lost a small (2%) amount of weight lower than that 
typically associated with NAFLD improvement [10]. While 
no differences between the dietary groups were observed in 
the reductions of liver fat and body weight, improvements 
in total cholesterol, plasma triglycerides, and HbA1c lev-
els were observed in the Mediterranean diet group; in line 
with the body of evidence suggesting this dietary pattern 
reduces metabolic risk factors and cardiovascular disease 
risk [11–13].
Dietary assessment for nutrition research can be divided 
into two distinct groups that either assess quantitatively 
short-term, daily nutrient intake through dietary records and 
interviewer-aided 24-h dietary recalls; or assess long-term 
habitual food consumption through food frequency ques-
tionnaires (FFQ). Respondent-led dietary records, such as 
4-day diet diaries (4DDD), require a level of participant bur-
den that has been well-characterised as a limitation of use, 
alongside other limitations such as reactivity bias (change 
in behaviour due to monitoring of behaviour [14]), errors 
in estimation of portion sizes, and non-compliance [15]. 
Similar limitations exist for FFQs, which while typically 
used for large population studies, may be extensive and time-
consuming, with significant participant burden, such as the 
198-item FFQ from the European Prospective Investigation 
into Cancer and Nutrition (EPIC) study [16]. FFQs are rou-
tinely adapted, often for concision, and typically validated 
for a specific population being studied. For example, the 
217-item FFQ created for the UK Women’s cohort study 
[17] was utilised by Cleghorn and colleagues [18] to validate 
an abridged, 20-item short FFFQ (SFFQ) for the purpose of 
assessing dietary quality conveniently in UK adults, irre-
spective of gender.
While the advantages of FFQs include ease of admin-
istration, particularly in settings lacking formal dietetic 
support, and the ability to embed questions pertaining to 
portion size [15], limitations to these exist. Studies utilis-
ing doubly labelled water to accurately measure total energy 
expenditure and/or urinary nitrogen as a biomarker of pro-
tein intake, have shown FFQs (and indeed also multiple 24 h 
recalls) severely underestimate absolute intakes of energy 
and protein [19, 20]. Although often polarised debates have 
ensued about the utility of these instruments in nutritional 
epidemiological research, nonetheless dietary data derived 
from these imperfect instruments have proven to be useful 
in addressing important research and public policy ques-
tions [21]. The administration of multiple short term dietary 
assessment instruments is accepted as providing more valid 
dietary information; and new technologies, including web-
based and smartphone applications, now permit low-cost 
dietary assessment at scale [22]. However, doubly labelled 
water studies suggest caution is still warranted for energy 
estimates from these [23]. The use of electronic tools in low 
resource settings and in low literacy populations is still lim-
ited [24].
In the context of clinical care, dietary assessment is used 
alongside biochemical, physical, and anthropometric meas-
urements [15]. Dietary assessment should be used to provide 
individualised dietary advice and to evaluate the success of 
interventions to improve diet and morbidity associated with 
chronic conditions such as obesity, diabetes and NAFLD. 
However, many primary care and tertiary referral settings 
lack resources for specialist dietetic support. Brief dietary 
assessment tools, responsive to dietary changes, can allow 
health professionals with minimal nutrition knowledge to 
quickly identify areas of concern and help set and moni-
tor food-based dietary goals for their patients [25]. While 
several disease-specific tools exist and have been used in 
clinical practice, the majority of these have been developed 
and evaluated in the US for dietary management of cardio-
vascular disease and type 2 diabetes [25]; to our knowledge 
no such instrument has been developed for NAFLD patients 
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or for a European population. Therefore, the aim of this 
research was to develop and validate a short food frequency 
questionnaire (SFFQ) capable of assessing foods and drinks, 
associated with obesity and NAFLD, consumed during a 
‘typical’ week over the past month, which could be used in 
settings lacking specialist dietetic support in an efficient and 
cost-effective manner. In addition, we aimed to characterise, 
for the first time, the dietary intakes of Irish patients with 
a diagnosis of NAFLD in tertiary care using the 4 day diet 
diary (4DDD) reference method.
Materials and methods
Study participants
Given the aim of developing a SFFQ for use with NAFLD 
patients in tertiary care, 55 consenting participants over 
the age of 18, with a Fibroscan and/or liver biopsy-based 
diagnosis of NAFLD, were recruited from the Hepatology 
Department in St James’ Hospital, Dublin, Ireland between 
January and September 2017 during their routine clinic vis-
its. Ethical approval was obtained from both St James’ Hos-
pital/Adelaide and Meath Research Ethics Committee (ref 
2017-01) and the Faculty of Health and Medical Sciences 
Ethics Committee, University of Surrey (1271-FHMS-17); 
and this cross-sectional analysis was conducted in accord-
ance with the 1964 Declaration of Helsinki and its later 
amendments. Exclusion criteria were: nutritional counsel-
ling in last 24 months, under the age of 18, and diagnosis of 
any other liver disease including hepatitis C and hepatitis B, 
coeliac disease, Wilson’s disease, autoimmune hepatitis or 
alcoholic fatty liver disease. Demographics, anthropometric 
and other related clinical data were recorded as a part of 
routine clinical care.
Short food frequency questionnaire (SFFQ; test 
method)
A semi-quantitative SFFQ was developed using questions 
from previously validated instruments [16, 18], and using 
expert knowledge about culturally specific foods, to tailor 
the tool to an Irish population. The 20-item SFFQ vali-
dated by Cleghorn and workers [18] for the assessment of 
dietary quality, based on intakes of fruits, vegetables, oily 
fish, free sugars and fat, in a UK population, was used as a 
starting point. Additional questions were adopted from the 
EPIC FFQ [16] to expand on intakes of refined carbohy-
drates, as well as high-fat foods, and highly processed foods 
implicated in NAFLD pathogenesis. Frequency was based 
‘on a typical week, over the last month or so’, and answers 
corresponded to one out of eight options, with categories 
ranging from ‘rarely or never’ to ‘5 + times a day for the 
carbohydrate group, and from ‘rarely or never’ to ‘7 + times 
a week’ for the protein and fat group. Additional questions 
related to food preparation, alcohol consumption, and food 
consumed outside of the home appended the SFFQ. The 
resulting 48-item, SFFQ (Supplementary file) was admin-
istered to each participant by the same researcher in an 
interview that lasted approximately 20 min. While the FFQ 
itself only briefly described a portion size using the phrasing 
from the Cleghorn SFFQ [18], ‘a portion includes: a hand-
ful of grapes, an orange, a serving of carrots, a side salad, a 
slice of bread, a glass of pop’, standard portion sizes from 
the healthy eating guidelines of the Food Safety Authority 
of Ireland (FSAI) [26] were explained at interview. Food 
groupings were derived from the, largely similar, groupings 
used by the Cleghorn and EPIC instruments [16, 18].
Four‑day diet diary (4DDD; reference method)
All participants were advised on how to complete a detailed 
written 4DDD, on 2 week days and 2 weekend days, which 
was returned by mail. The 8-page template consisted of 3 
columns for recording type of meal (i.e. before breakfast, 
breakfast, before lunch, lunch, afternoon, evening meal, 
evening/night), time of meal, and the weights and sizes of 
foods/meals. Participants were encouraged to weigh foods 
whenever possible, and where this was not possible they 
were asked to give as much detail as practical on portion size 
using information from package information and household 
measures. These were converted into weights by a trained 
analyst using manufacturer’s information and standard por-
tion sizes [26]. Nutrient intakes were analysed using the 
online, myfood24™ dietary assessment tool [27]. Diaries 
were inputted as four 24 h periods and mean intakes were 
calculated for each nutrient for each participant. Of note, 
the underpinning database for myfood24™ expands greatly 
on the UK food composition dataset [28] of ~ 3300 items by 
incorporating an additional > 40,000 generic and branded 
items [29] commonly found in UK and Irish supermarkets.
Under-reporting was calculated based on the ratio of 
energy intake (EI) from the 4DDDs to estimated energy 
requirements (EER) [30]. The EER for all participants were 
calculated using sex-, age- and weight-specific equations 
coupled with physical activity levels [31]. The physical 
activity level for sedentary lifestyle (1.55) was applied to 
all participants based on reported activity levels and lack 
of an objective measure of physical activity in the study 
design. The expected EI:EER ratio is set at 1:1, and those 
with intakes below and above this ratio were classified as 
misreporting [32].
For comparison between the two instruments, portion 
sizes were assigned to each food item in the SFFQ, and mul-
tiplied by the chosen frequency response [33]. These were 
either standard portion sizes from FSAI [26], for example 
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80 g of fruit or vegetables; or, derived from the average 
portion size of the food items taken from the myfood24™ 
database for the derivation of the sugar and fat estimations. 
Details of all calculations and food items used for nutrient 
derivations for the SFFQ are provided within the metadata 
accompanying our dataset (Supplementary file 1) and this, 
along with the SFFQ and patient information leaflet devel-
oped in this project, is available through an open access 
repository under a Creative Commons Attribution licence 
(CC-BY 4.0) [34].
Statistical methods
Statistical analysis was done using GraphPad Prism v7.0 
(GraphPad Software Inc, La Jolla, CA). Data were tested 
for normality using D’Agostino-Pearson omnibus and Sha-
piro–Wilk tests and results are presented as median and 
interquartile range (25th, 75th percentile). To compare the 
NAFL and NASH groups, the Mann–Whitney U test was 
used. Comparisons for categorical variables were done 
using Fisher’s exact test. Agreement (validity) between the 
SFFQ and 4DDD instruments for fruit, vegetables, total 
sugar, and total fat was assessed as recommended [35] by 
multiple statistical methods for numerical variables. These 
included the Wilcoxon matched-pairs signed rank test and 
associated Spearman’s correlation to assess median differ-
ences and effectiveness of pairing; along with Bland Altman 
(difference vs mean) plots with regression analysis to detect 
proportional differences and to indicate the direction and 
magnitude of the bias. In addition, Cohen’s kappa (κ) test 
was used to determine the ability of the SFFQ to rank indi-
viduals categorically based on lower (< 60 g/day, ~ 10% total 
energy) or higher (≥60 g/d) sugar intakes. Throughout, a P 
value < 0.05 was considered statistically significant.
Table 1  Demographic, 
anthropometric and biochemical 
characteristics
Values are presented as number of participants (% of sample) or median (25th; 75th percentile)
ALT Alanine aminotransferase, AST aspartate aminotransferase, BMI body mass index, CAP controlled 
attenuation parameter, dB/m decibels per milliwatt, GGT gamma-glutamyl transferase, HbA1c glycated 
haemoglobin, HDL high density lipoprotein, kPa kilopascal, LDL low density lipoprotein, LSM liver stiff-
ness measurement, NAFL non-alcoholic fatty liver, NAFLD non-alcoholic fatty liver disease, NASH non-
alcoholic steatohepatitis
a Mann–Whitney U test performed for continuous variables (age, weight, height, BMI) and Fisher’s exact 
test performed for categorical variables (number of patients with and without concomitant disease in each 
cohort) comparing NAFL with NASH
b The FibroScan LSM and CAP Scores are acquired from transient elastography (specialised ultrasound) of 
liver and are used to noninvasively diagnose fibrosis and steatosis in the liver, respectively
c NAFLD fibrosis score is an algorithm based on routine clinical measurements used to predict the presence 
of liver fibrosis = 1.675 + 0.037 × age + 0.094 × BMI + (1.13 if diabetes) + 0.99 × (AST/ALT) − 0.014 × 
platelet − 0.66 × albumin
Characteristics Total (n = 55) NAFL (n = 42) NASH (n = 13) P  valuea
Male, female n (%) 29, 26 (53, 47) 25, 17 (60, 40) 4, 9 (31, 69) –
Age (years) 58 (52; 65) 55 (52; 64) 58 (50; 65) 0.9880
Weight (kg) 92 (81;103) 93.5 (84; 102.5) 84 (77; 101.8) 0.3837
Height (cm) 168 (161; 175) 168 (162; 175) 165 (155; 174) 0.3515
Body mass index (kg/m2) 33.2 (29.3; 36) 32.2 (29.3; 36.2) 33.2 (29.7; 35.8) 0.9228
Dyslipidaemia n (%) 26 (47%) 18 (43%) 8 (62%) 0.3425
Diabetes n (%) 19 (35%) 9 (22%) 10 (77%) 0.0005
Hypertension n (%) 25 (46%) 15 (36%) 10 (77%) 0.012
Triglycerides (mmol/L) 1.9 (1.3; 2.7) 1.9 (1.2; 2.7) 2.2 (1.5; 2.8) 0.3486
HDL (mmol/L) 1.3 (0.9; 1.4) 1.3 (1.0; 1.4) 1.2 (0.9; 1.3) 0.2328
LDL (mmol/L) 2.4 (1.9; 2.9) 2.5 (2.0; 2.9) 2.1 (1.5; 2.4) 0.1129
HbA1c (mmol/mol) 39.5 (43.3; 46.8) 37.0 (34.0; 43.8) 45.5 (40.8; 47.3) 0.0325
ALT (IU/L) 42 (25; 61) 38 (24; 56) 57 (31; 81) 0.0394
AST (IU/L) 31 (22; 40) 26 (22; 32) 52 (38; 83) < 0.0001
GGT (IU/L) 60 (34; 84) 53 (33; 80) 97 (49; 190) 0.0178
FibroScan LSM (kPa)b 6.9 (5.6; 11.3) 6.3 (5.2; 7.8) 12.9 (10.6; 14.5) < 0.0001
CAP Score (dB/m)b 316 (297; 355) 312 (292; 352) 338 (307; 358) 0.2850
NAFLD Fibrosis  Scorec – 1.25 (– 2.68; – 
0.36)
– 1.73 (– 2.79; – 0.89) – 0.36 (– 1.25; – 0.16) 0.0551
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Results
Between January and September 2017, 81 consecutive 
patients attending the St James’ Hospital NAFLD clinic were 
approached for the study. Of the 55 consenting participants 
who completed both SFFQ and 4DDDs, 42 had NAFL and 
13 had a biopsy-confirmed, diagnosis of NASH; and their 
characteristics are outlined in Table 1. The median (25th, 
75th percentile) age of participants was 58 (52; 65). Gender 
was evenly split in the overall cohort, with 53% male and 
47% female participants, and 96% of the cohort were over-
weight or obese using BMI classifications. Although there 
was no difference in median BMI between the NAFL, 32.2 
(29.3; 36.2 kg/m2), and NASH groups 33.2 (29.7; 35.8 kg/
m2), patients with NASH were more likely to have concomi-
tant diagnoses of type 2 diabetes (77% vs. 22%; P = 0.0005) 
and hypertension (77% vs. 36%; P = 0.012). Patients with a 
diagnosis of type 2 diabetes and dyslipidaemia were typi-
cally treated with medications such as metformin and statins; 
as such, median HbA1c levels, 39.5 (43.3; 46.8 mmol/mol) 
and LDL levels, 2.4 (1.9; 2.9 mmol/L) were well-managed 
within this population, although triglycerides, 1.9 (1.3; 
2.7 mmol/L) were somewhat elevated. NASH patients had 
higher Fibroscan scores, 12.9 (10.6; 14.5 kPA), than NAFL 
patients 6.3 (5.2; 7.8) (P ≤ 0.0001); and similarly had ele-
vated liver enzymes when compared with NAFL patients; 
ALT (57 vs 38 IU/L; P = 0.0394), AST (52 vs 26 IU/L; 
P ≤ 0.0001), and GGT (97 vs 53 IU/L; P = 0.0178).
Initial dietary analysis from the 4DDD (Table 2) high-
lighted median energy intakes well below EER for all par-
ticipants at 73% (60; 97); suggesting widespread under-
reporting in this cohort. While there were no differences 
in macronutrient consumption between NAFL and NASH 
patients, median intakes of saturated fatty acids (SFA), were 
higher than dietary guidelines at 13 (10, 16) percent total 
energy (%TE). Similarly, intakes of total sugars, 15 (11; 
21) %TE, were higher than current guidelines worldwide 
[36] to keep free sugars to 5–10%TE. Although median 
levels of total fat at 34 (31; 41) %/TE were below Irish 
and EU recommendations of < 35% total energy, 47% of 
the cohort exceeded this. Relatedly, and perhaps unusually 
for a NAFLD population, reported protein intakes did not 
generally exceed reference intakes, with 38% of the cohort 
not meeting the 0.75 g protein per kilogram of body weight 
recommendation [37]. The vast majority of patients reported 
Table 2  Energy and 
macronutrient intakes calculated 
from 4-day diet diaries from 
patients with NAFL and NASH
Values are presented as median (25th; 75th percentile)
EER estimated energy requirement, NAFL non-alcoholic fatty liver, NASH non-alcoholic steatohepatitis, 
SFA saturated fatty acids, MUFA monounsaturated fatty acids, n6 omega 6, PA physical activity, PUFA 
polyunsaturated fatty acids, %TE percent total energy
a Males: EER = 662 – (9.53 × age [y]) + PA x [(15.91 × weight [kg]) + (539.6 × height [cm])] [31]
Females: EER = 354 – (6.91 × age [y]) + PA x [(9.36 x weight [kg]) + (726 × height [cm])] [31]
Total (n = 55) NAFL (n = 42) NASH (n = 13) p value
Energy intake (kcal/day) 1625 (1390; 2090) 1621 (1389; 2102) 1699 (1398; 1999) 0.9143
EER (kcal/day)a 2263 (1897; 2635) 2272 (1871; 2644) 2064 (1761; 2289) 0.1973
Energy intake/requirement (%) 73 (60; 97) 72 (63; 96) 86 (59; 104) 0.6433
Macronutrients/foods
 Protein (g/day) 71.8 (66.6; 84.7) 72.2 (67.4; 86.9) 70.7 (56.9; 75.6) 0.331
 Fat (g/day) 65.2 (49.1; 87.01) 62.9 (49.6; 83.2) 74 (46.1; 93.0) 0.8068
 Fat (%TE) 34 (31; 41) 34 (31; 39) 35 (33; 44) 0.4989
 SFA (g/day) 23.5 (17.2; 32.4) 23 (18.2; 34.1) 23.5 (11.4; 30.9) 0.3116
 SFA (%TE) 13 (10; 16) 13 (11; 17) 11 (8; 14) 0.1901
 n6 PUFA (g/day) 2.3 (1.3; 4.8) 2.2 (1.2; 4.4) 3.7 (1.7; 6.0) 0.1308
 n6 PUFA (%TE) 1.2 (0.8; 2.3) 1.1 (0.8; 1.8) 1.5 (1.2; 3.4) 0.0944
 n3 PUFA (g/day) 0.4 (0.2; 0.6) 0.4 (0.2; 0.6) 0.5 (0.3; 0.6) 0.5501
 n3 PUFA (%TE) 0.2 (0.1; 0.3) 0.2 (0.1; 0.3) 0.2 (0.2; 0.4) 0.5371
 MUFA (g/day) 21.4 (16.5; 32.2) 21.0 (16.8; 31.5) 23.6 (12.6; 34.2) 0.5633
 MUFA (%TE) 12 (10; 13) 12 (10; 13) 13 (11; 15) 0.1526
 Carbohydrate (g/day) 178 (160; 222) 183 (160; 226) 176 (161; 216) 0.7766
 Carbohydrate (%TE) 45 (41; 50) 45 (44; 49) 45 (37; 52) 0.8525
 Total sugars (g/day) 66.1 (45.2; 93.8) 67.7 (45.0; 96.1) 59.6 (50.0; 91.9) 0.822
 Total sugars (%TE) 15 (11; 21) 16 (11; 20) 16 (13; 17) 0.8679
 Dietary fibre (g/day) 12.3 (8.8; 14.8) 11.9 (8.8; 13.6) 13.8 (9.9; 15.7) 0.2261
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intakes of both omega 6 polyunsaturated fatty acids, (n6 
PUFA) 1.2 (0.8; 2.3) %TE, and omega 3 PUFA, (n3 PUFA) 
0.2 (0.1; 0.3) %TE, which were well below recommended 
guidelines of 1.5% and 0.5%, respectively. Dietary fibre 
intakes, 12.3 (8.8; 14.8) g/day, were similarly less than 50% 
of the recommended 25 g/day for an adult [37]. Micronutri-
ent intakes were within adequate range of the RDA for most 
nutrients, including B1, B2, B3, B6, B12 and folate, as well 
as iron, zinc, copper and vitamin C (data not shown). Dietary 
vitamin D intakes were on the low-normal scale, at 1.7 (1.1; 
3.0 range 0–10) µg/day; whereas median sodium intakes, 
2668 (2119; 3078) mg/day exceeded the upper limit RDA 
(< 2500 mg/day) for many patients [37].
Prioritising fruit, vegetables, sugars, and fat, as critical 
food items and nutrients implicated in NAFLD; we exam-
ined intakes assessed by the SFFQ in relation to the 4DDD 
(Table 3). Fruit and vegetable intakes were low in the cohort 
in general, equivalent to 1.5 standard portions of each as 
assessed by 4DDD; fruit: 125 (55–216) g/d, vegetable: 118 
(86–181) g/day. Median differences were very small for fruit 
(– 4%) and sugar (+ 3%), but somewhat larger for fat (– 23%) 
and vegetables (– 52%). Spearman’s correlations between 
the two dietary assessment instruments were moderate 
and highly significant for fruit (r = 0.5123, P = 0.0001), fat 
(r = 0.4326, P = 0.0010) and sugar (r = 0.4079, P = 0.0020); 
while the vegetable measurement was more variable 
(r = 0.3983, P = 0.0026). The Wilcoxon matched pairs 
signed-rank sum test showed no significant differences in 
the median fruit and total sugar measurements between the 
SFFQ and the 4DDD; although differences were observed 
for fat (P < 0.0013) and vegetables (P < 0.0001; Table 3). 
Cohen’s kappa indicated fair agreement (κ = 0.347) between 
the SFFQ’s and 4DDD’s ranking of individuals categorically 
based on lower or higher sugar intakes.
Bland Altman analysis of bias, plotting difference vs the 
mean to assess comparability of two methods of clinical 
measurement [38], in tandem with linear regression analy-
sis was used to further assess agreement between the two 
methods, along with the distribution of bias (Fig. 1). Bias 
was minimal and evenly distributed for fat and fruit with the 
SFFQ underestimating fat (– 13.8 g/day; Fig. 1a) and slightly 
underestimating fruit (– 13.5 g/day; Fig. 1b) relative to the 
4DDD. Although the overall bias for sugar was a relatively 
small overestimation (+ 12.9 g/day), regression showed 
dose-dependency with more skew evident at larger intakes 
(Fig. 1c). Larger underestimations were observed for the 
SFFQ measurement of vegetables (– 54.2 g/day; Fig. 1d), 
with regression suggesting greater underestimation at higher 
intakes (Fig. 1d). In general, agreement intervals were broad 
(Fig. 1).
Discussion
This is the first study to characterise a cohort of adult Irish 
NAFLD patients and their dietary intakes. The majority of 
participants were obese and patients with biopsy-confirmed 
NASH were more likely to also be diagnosed with hyperten-
sion and type 2 diabetes. Dietary intakes were overwhelm-
ingly consistent with the typical ‘Western diet’ associated 
with obesity, with high intakes of sugar, sodium, total and 
saturated fat; and substantially low intakes of vitamin D, 
omega-3 polyunsaturated fat and dietary fibre. Under-
reporting was common but in line with what is typically 
observed in population studies [32]. We observed no dif-
ferences between the dietary intakes of patients diagnosed 
with simple steatosis (NAFL), and those diagnosed with 
steatohepatitis (NASH); rather, the vast majority of patients 
were consuming nutritionally poor diets, high in sugar, salt 
and saturated fat.
A primary objective was to develop and validate a mini-
mally burdensome tool for assessing dietary intakes in 
NAFLD patients. Improvement in the clinical outcomes of 
NAFLD has been generally observed with a weight loss of 
5–10% [6] and for this reason, dietary and lifestyle changes 
aimed at weight loss underpin clinical management guide-
lines for NAFLD [2, 3, 5]. While dietary assessment and 
dietetic management should ideally be made available to 
NAFLD patients in primary care and tertiary referral set-
tings, this is not always possible. Therefore, brief dietary 
assessment tools, responsive to dietary changes, can allow 
health professionals to quickly identify areas of concern 
and help set and monitor food-based dietary goals for their 
patients [25]. Several tools exist for dietary management of 
Table 3  Comparisons of median 
intakes from SFFQ and 4DDD 
(n = 55) for total fat, fruit, sugar 
and vegetable





Median (25th–75th) Median (25th–75th) P rs P
Fat (g/day) 50 (33–77) 65 (49–87) 0.0013 0.4326 0.0010
Fruit (g/day) 120 (29–280) 125 (55–216) 0.2176 0.5123 < 0.0001
Sugars (g/day) 68 (31–111) 66 (45–94) 0.4977 0.4079 0.0020
Vegetables (g/day) 57 (29–120) 118 (86–181) < 0.0001 0.3983 0.0026
European Journal of Nutrition 
1 3
cardiovascular disease and type 2 diabetes, and have suc-
cessfully been used in clinical practice. However, the major-
ity of these have been developed and evaluated in the US, 
and are not fully applicable to a European population [25].
To our knowledge, no such instrument (a brief dietary 
assessment tool, responsive to dietary changes) has been 
developed for NAFLD patients. As FFQs are easily adminis-
tered in settings lacking formal dietetic support, and portion 
sizes are built into the questions reducing measurement error 
[15], we aimed to develop and validate an SFFQ for use with 
NAFLD patients. Typically, FFQs are routinely validated 
for a specific population being studied. Here, we adapted a 
concise 20-item SFFQ previously validated for conveniently 
assessing dietary quality in UK adults [18], considered a 
reasonable starting place for an inner-city Irish cohort of 
NAFLD patients, by adding additional questions from the 
EPIC-FFQ [16], emphasising questions related to refined 
carbohydrates, sugar-sweetened beverages, high-fat foods, 
and ultra-processed foods. The result was the 48-item SFFQ 
employed in this study.
The relative validity of our newly developed SFFQ was 
examined in relation to 4DDDs from 55 NAFLD patients, 
focusing on results for sugar, fat, fruit, and vegetables. This 
approach to validation of dietary assessment tools has been 
extensively utilised in the literature [18, 39–42]. Correlations 
between the two instruments for sugar, fat and fruit were 
highly significant and all nutrients had moderate correlation 
coefficients (0.4–0.51) very much in line with, or better than, 
reported correlations in comparable studies. For example, 
the correlation between fat measurements from the instru-
ments here at 0.43 was much stronger than those observed 
by Cleghorn (0.22) [18], or Steinemann (0.37) [43]. The 
correlation (0.41) between the SFFQ and 4DDD sugar meas-
urements, while not as strong as Yuan et al. (0.53) [26], was 
stronger than the 0.15 and 0.10 found by Cleghorn [18] and 
with the much longer (109 items) instrument of Tabacchi 
[44]. This justified our approach of adding further sugar-
related questions to the concise set used in the Cleghorn 
20-question tool. Bland–Altman plots were used to examine 
the average and the difference between the new SFFQ and 
the 4DDD instruments. This analysis demonstrated minimal 
bias in the SFFQ for fat, sugar and fruit intakes, but some 
underestimation by the SFFQ in vegetable intakes and some 
skewing at higher intakes for sugar and vegetables. Nonethe-
less, the methods were significantly correlated and showed 
broad comparability in the Bland Altman analysis.
The process of validating a new FFQ against a 4DDD 
is well-described as an acceptable, if flawed, validation 
method [45]. A 4DDD is an imperfect reference instrument, 
as measurement errors are inherent to this method of dietary 
assessment, and may result in correlated errors between 
both instruments [46, 47]. The potential for reactivity and/
or recall biases are high when utilising most forms of die-
tary assessment instruments, particularly among overweight 
Fig. 1  Bland Altman plots 
showing difference vs mean for 
the SFFQ and 4DDD measure-
ments of: a sugar; b fat; c fruit; 
and d vegetable intakes. Bias 
and 95% limits of agreement 
shown in dotted horizontal 
lines. Linear regression and 
95% confidence intervals are 
solid line and dashed lines, 
respectively
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and obese individuals [15], which accounted for 96% of our 
cohort. While the potential for conscious energy restrictions 
to facilitate weight loss in some participants cannot be ruled 
out, the under-reporting of energy intakes observed in the 
4DDDs here suggest some recall bias likely. Limitations of 
this work include the use of a sole patient cohort and risk of 
selection bias, which mean that it may not be generalizable 
to other populations. As previously discussed, FFQs are not 
instruments for the precise measurement of absolute energy 
or nutrient intakes [19, 20] but may be useful as adjunct 
clinical tools with acceptable ranking abilities [23]. Limita-
tions in all concise tools surround choice of questions and 
we note this tool did not have questions specifically around 
healthful aspects of the Mediterranean diet such as nuts, 
seeds and specifically quantifying olive oil consumption, 
which will be addressed in future iterations.
Strengths of the study include the fact that it is the first 
characterisation of an Irish NAFLD cohort and their dietary 
intakes, the use of 4DDDs, the use of the comprehensive 
myfood24 database, and the researcher-led administration of 
the FFQ. While the gold-standard methodology for validat-
ing an FFQ is against biomarkers [15], these have their own 
limitations and were judged outside the scope of this study. 
Nonetheless, urinary sugars biomarkers, in particular, would 
be an interesting choice for future research; capturing two 
important factors at once: a form of calibration or calculat-
ing an adjustment equation for misreporting, as well as being 
a measure of dietary exposure of sugars [48]. Ideally, the 
examination of the SFFQ alongside urinary biomarkers in 
response to a dietary intervention would clarify the respon-
siveness of this instrument to dietary changes.
In the context of validating the novel SFFQ, 55 4DDDs 
from a cohort of Irish NAFLD patients were analysed and 
assessed. NAFLD in Ireland has been under-researched and 
these cross-sectional data are the first characterisation of 
an Irish NAFLD cohort and their dietary intakes. Dietary 
intakes were overwhelmingly consistent with the typical 
Western dietary patterns seen in other NAFLD populations 
around the world, with high-fat, high-sugar, high-sodium, 
low omega-3 polyunsaturated fat, and low fibre intakes dom-
inating. A future aim is to further develop the SFFQ into an 
electronic tool capable of rapidly categorising a ‘NAFLD 
risk diet’ with the aim of providing effective key messages 
(e.g. decrease sugar intake), particularly in primary and 
tertiary care where resources are limited. While prevalence 
data for NAFLD in Ireland is lacking, population-based obe-
sity data highlight a significant clinical burden, with 71% of 
older adults now classified as overweight and obese [49]. 
These figures agree with a Lancet report that shows Ireland 
is set to become the most obese nation in Europe by 2025 
[50]. In adults with obesity and concomitant diseases such 
as type 2 diabetes, NAFLD incidence can increase to 69%. 
Additional factors, a review of which were outside the scope 
of this study but include Ireland’s higher incidence rates per 
capita of hereditary hemochromatosis, and higher rates per 
capita of binge-pattern alcohol consumption, justify con-
cerns over a burgeoning liver disease epidemic. These data 
highlight the urgent need to identify those at risk of NAFLD 
in the community, and why primary and tertiary care teams 
require additional tools to rapidly and reliably assess dietary 
intakes that potentiate the disease state.
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